A guanine nucleotide-independent inwardly rectifying cation permeability is associated with P2Y(1) receptor expression in Xenopus oocytes

被引:28
作者
OGrady, SM [1 ]
Elmquist, E [1 ]
Filtz, TM [1 ]
Nicholas, RA [1 ]
Harden, TK [1 ]
机构
[1] UNIV N CAROLINA,SCH MED,DEPT PHARMACOL,CHAPEL HILL,NC 27599
关键词
D O I
10.1074/jbc.271.46.29080
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The functional properties of the G protein-coupled P2Y(1) receptor were investigated in Xenopus oocytes. Incubation of oocytes expressing either the human or turkey P2Y(1) receptor with adenine nucleotide agonists resulted in an increase in Cl- current and activation of a novel cation current with an inwardly rectifying current-voltage relationship. Activation of either the human P2Y(2) (P-2U-purinergic) or M1 muscarinic receptor expressed in oocytes resulted in an increase in Cl- current similar to that observed in P2Y(1) receptor-expressing oocytes but had no effect on cation current. P2 receptor agonists stimulated both the cation current and Cl- current in P2Y(1) receptor expressing oocytes with EC(50) values and an order of potency (2-methylthioadenosine diphosphate > 2-methylthioadenosine triphosphate (2MeSATP) > ATP > UTP) that were similar to those previously observed for activation of phospholipase C in 1321N1 human astrocytoma cells stably expressing the human or turkey P2Y(1) receptor. The P2Y receptor antagonists suramin and pyridoxal phosphate 6-azophenyl-2'-4'-disulfonic acid both shifted to the right the concentration-response relationship for 2MeSATP for stimulation of oocyte currents. Although injection of oocytes with either GDP beta S (granuyl-5'-yl thiophosphate) or GTP gamma S (guanosine 5'3-O-(thio)triphosphate) resulted in loss of adenine nucleotide-promoted Cl- channel activation, neither guanine nucleotide altered the 2MeSATP-stimulated cation current. These data are consistent with the view that activation of the novel cation current by the P2Y(1) receptor does not involve a G protein. Tail current analysis of the novel P2Y(1) receptor-associated cation conductance revealed that the open channel current-voltage relationship was outwardly rectifying with a reversal potential of -38 mV for the turkey P2Y(1) receptor and -36 mV for the human P2Y(1) receptor. Replacement of Na+ with K+ ions in the bathing solution produced a shift in reversal potential to near zero mV, but significant outward rectification remained. The cation current was not permeable to either Ca2+ or Ba2+ and exhibited steady-state inactivation at holding potentials below -60 mV. These results indicate that the P2Y(1) receptor exhibits both metabotropic properties and a novel G protein-independent ionotropic response when expressed in Xenopus oocytes.
引用
收藏
页码:29080 / 29087
页数:8
相关论文
共 29 条
[1]   PURINOCEPTORS - ARE THERE FAMILIES OF P2X AND P2Y PURINOCEPTORS [J].
ABBRACCHIO, MP ;
BURNSTOCK, G .
PHARMACOLOGY & THERAPEUTICS, 1994, 64 (03) :445-475
[2]   G-PROTEIN-COUPLED P-2 PURINOCEPTORS - FROM MOLECULAR-BIOLOGY TO FUNCTIONAL-RESPONSES [J].
BOARDER, MR ;
WEISMAN, GA ;
TURNER, JT ;
WILKINSON, GF .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1995, 16 (04) :133-139
[3]  
BOYER JL, 1989, J BIOL CHEM, V264, P884
[4]   NEW STRUCTURAL MOTIF FOR LIGAND-GATED ION CHANNELS DEFINED BY AN IONOTROPIC ATP RECEPTOR [J].
BRAKE, AJ ;
WAGENBACH, MJ ;
JULIUS, D .
NATURE, 1994, 371 (6497) :519-523
[5]   IS THERE A BASIS FOR DISTINGUISHING 2 TYPES OF P2-PURINOCEPTOR [J].
BURNSTOCK, G ;
KENNEDY, C .
GENERAL PHARMACOLOGY, 1985, 16 (05) :433-440
[6]   MOLECULAR-CLONING AND FUNCTIONAL-ANALYSIS OF A NOVEL P-2 NUCLEOTIDE RECEPTOR [J].
CHANG, KG ;
HANAOKA, K ;
KUMADA, M ;
TAKUWA, Y .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (44) :26152-26158
[7]   Cloning and functional expression of a human uridine nucleotide receptor [J].
Communi, D ;
Pirotton, S ;
Parmentier, M ;
Boeynaems, JM .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (52) :30849-30852
[8]   SIGNAL-TRANSDUCTION VIA P2-PURINERGIC RECEPTORS FOR EXTRACELLULAR ATP AND OTHER NUCLEOTIDES [J].
DUBYAK, GR ;
ELMOATASSIM, C .
AMERICAN JOURNAL OF PHYSIOLOGY, 1993, 265 (03) :C577-C606
[9]  
FILTZ TM, 1994, MOL PHARMACOL, V46, P8
[10]  
FILTZ TM, 1996, IN PRESS PURINERGIC